Indeed, Bregs seem to attenuate immune response in cancers [76,77], but also in other inflammatory diseases [78], activated through the TLR, BCR, CD40/CD40L or B-cell activating factor (BAFF) -signaling pathways. Here, TNFSF13B is linked to cancer.